The top 20 #MajorPROsASH list is complete! A truly phenomenal year at #ASH22 with a (growing!) plethora of PRO abstracts from which to choose. Please send along any others you found, and safe travels back home. #MajorPROs cc @ASH_hematology@twitter.com

RT @majorajay@twitter.com

Here we go! Announcing this year's top 20 patient-reported outcomes abstracts at #ASH22. Follow along in this thread for the latest thought-provoking (and provocative!) #qualityoflife studies in hematology. 🧵#MajorPROs #MajorPROsASH #ASH2022 cc @ASH_hematology@twitter.com

Next bolus of @ASH_hematology@twitter.com #ASH22 patient-reported outcomes abstracts in this thread! #MajorPROs #MajorPROsASH

Distress on NCCN Distress Thermometer = inferior overall survival in AML. What drives this and amenable to intervention? #leusm

RT @majorajay@twitter.com

Here we go! Announcing this year's top 20 patient-reported outcomes abstracts at #ASH22. Follow along in this thread for the latest thought-provoking (and provocative!) #qualityoflife studies in hematology. 🧵#MajorPROs #MajorPROsASH #ASH2022 cc @ASH_hematology@twitter.com

🐦🔗: https://twitter.com/majorajay/status/1601015620128342016

Just stopped by the #ASH22 poster hall and there are a HUGE number of PRO abstracts, way more than #ASH21. 🫶🏼👏🏾🎉

Going to tweet out a few fantastic patient-reported outcomes posters in this thread. 🧵 #MajorPROs #MajorPROsASH

Good morning, @ASH_hematology@twitter.com #ASH22! Added a few more early-morning PRO abstracts to the below thread over coffee. 👇🏽👇🏽 See you all soon! #MajorPROsASH

RT @majorajay@twitter.com

Here we go! Announcing this year's top 20 patient-reported outcomes abstracts at #ASH22. Follow along in this thread for the latest thought-provoking (and provocative!) #qualityoflife studies in hematology. 🧵#MajorPROs #MajorPROsASH #ASH2022 cc @ASH_hematology@twitter.com

Here we go! Announcing this year's top 20 patient-reported outcomes abstracts at #ASH22. Follow along on my Twitter thread for the latest thought-provoking (and provocative!) #qualityoflife studies in hematology. 🧵#MajorPROs #MajorPROsASH #ASH2022

https://twitter.com/majorajay/status/1601015620128342016?t=h4Pw0R9NyNAd4zkBt9hErQ&s=19

Here we go! Announcing this year's top 20 patient-reported outcomes abstracts at #ASH22. Follow along in this thread for the latest thought-provoking (and provocative!) #qualityoflife studies in hematology. 🧵#MajorPROs #MajorPROsASH #ASH2022 cc @ASH_hematology@twitter.com

Happy #ASH22 week! After reviewing all the patient-reported outcomes abstracts @ash_hematology@twitter.com this year, I'll be highlighting my top 20 #MajorPROs abstracts starting tomorrow, with new additions I find down in #NOLA. Stay tuned! #MajorPROsASH

Very proud of this #ASH22 abstract which elucidates why just reporting global QOL as a patient-reported outcome is insufficient in capturing dynamic changes in symptom burden in the trial setting. #mmsm #MajorPROs #MajorPROsASH

https://ashpublications.org/blood/article/140/Supplement%201/12593/489446/Global-Health-Status-Inadequately-Captures